Literature DB >> 7989966

Ictal and interictal brain SPECT imaging in epilepsy using technetium-99m-ECD.

F Grünwald1, C Menzel, L Pavics, J Bauer, A Hufnagel, K Reichmann, R Sakowski, C E Elger, H J Biersack.   

Abstract

UNLABELLED: The aim of this study was to evaluate the use of 99mTc-ethyl cysteinate dimer (ECD), also known as 99mTc-bicisate, in the presurgical evaluation of patients suffering from medically intractable epilepsy.
METHODS: Twenty-three brain SPECT studies (8 ictally and 15 interictally) were performed on 16 patients with a high-resolution annular SPECT system (CERASPECT). For the ictal studies, the tracer was injected in the very early phase of the seizure. The delay between seizure onset and 99mTc-ECD injection was 2-20 sec.
RESULTS: Interictally, all patients showed circumscribed hypoperfusions. In four patients, the SPECT lesion represented only structural defects. Circumscribed increased tracer uptake was observed in all ictal studies. For all patients with temporal lobe epilepsy without significant mass lesion, in whom an interictal and ictal 99mTc-ECD-SPECT study could be obtained, the asymmetry index was 0.88 +/- 0.03 for the interictal and 1.23 +/- 0.08 for the ictal studies.
CONCLUSION: The data suggest that 99mTc-ECD is an effective marker of cerebral perfusion imaging in epilepsy. In comparison to other tracers, it has a high in vitro stability and is therefore particularly useful for ictal studies in the very early phase after seizure onset.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989966

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

Review 1.  Brain imaging during seizure: ictal brain SPECT.

Authors:  S R Kottamasu
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

Review 2.  Interventional brain SPECT--a review.

Authors:  H J Biersack; E Klemm; C Menzel; K Reichmann; W J Shih; F Grünwald
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

Review 3.  Where are we with nuclear medicine in pediatrics?

Authors:  H R Nadel
Journal:  Eur J Nucl Med       Date:  1995-12

4.  Comparative study of 99mTc-ECD and 99mTc-HMPAO for peri-ictal SPECT: qualitative and quantitative analysis.

Authors:  T J O'Brien; B H Brinkmann; B P Mullan; E L So; M F Hauser; M K O'Connor; J Hung; C R Jack
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

5.  Quantitative multi-compartmental SPECT image analysis for lateralization of temporal lobe epilepsy.

Authors:  Kourosh Jafari-Khouzani; Kost Elisevich; Kastytis C Karvelis; Hamid Soltanian-Zadeh
Journal:  Epilepsy Res       Date:  2011-03-30       Impact factor: 3.045

6.  Simultaneously Acquired MRI Arterial Spin-Labeling and Interictal FDG-PET Improves Diagnosis of Pediatric Temporal Lobe Epilepsy.

Authors:  A M Khalaf; H R Nadel; H M Dahmoush
Journal:  AJNR Am J Neuroradiol       Date:  2022-02-24       Impact factor: 3.825

Review 7.  [Imaging in the presurgical evaluation of epilepsy].

Authors:  Maria Ilyas-Feldmann; Bernd Vorderwülbecke; Mirja Steinbrenner
Journal:  Nervenarzt       Date:  2021-09-07       Impact factor: 1.297

8.  18F-fluorodeoxyglucose-PET and 99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease.

Authors:  F Grünwald; C Pohl; H Bender; A Hartmann; C Menzel; J Ruhlmann; E Keller; H J Biersack
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

9.  18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus.

Authors:  F Grünwald; A Schomburg; A Badali; J Ruhlmann; L Pavics; H J Biersack
Journal:  Eur J Nucl Med       Date:  1995-09

10.  Diagnosis of regional cerebral blood flow abnormalities using spect: agreement between individualized statistical parametric maps and visual inspection by nuclear medicine physicians with different levels of expertise in nuclear neurology.

Authors:  Euclides Timóteo da Rocha; Carlos Alberto Buchpiguel; Ricardo Nitrini; Sergio Tazima; Stela Verzinhase Peres; Geraldo Busatto Filho
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.